Dogwood Therapeutics, Inc. (DWTX) stock
DWTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.08+0.02 (+1.89%)
Close on Nov 17, 2026Market cap $36.71MP/E –Yield –
Dogwood Therapeutics cash
Cash and short-term investments held at the end of each period.
Dogwood Therapeutics's cash was $9.61M at Jun 30, 2026. For fiscal 2025 it was $6.52M, down 56.1% from the year before. The highest annual figure on record is $29.80M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.52M | -56.1% |
| FY2024 | Dec 31, 2024 | $14.85M | +347.6% |
| FY2023 | Dec 31, 2023 | $3.32M | -52.8% |
| FY2022 | Dec 31, 2022 | $7.03M | -49.8% |
| FY2021 | Dec 31, 2021 | $14.01M | -53.0% |
| FY2020 | Dec 31, 2020 | $29.80M | +9530.5% |
| FY2019 | Dec 31, 2019 | $309.38K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $9.61M | -28.3% |
| Q1 FY2026 | Mar 31, 2026 | $13.23M | -24.6% |
| Q4 FY2025 | Dec 31, 2025 | $6.52M | -56.1% |
| Q3 FY2025 | Sep 30, 2025 | $10.13M | +396.5% |
| Q2 FY2025 | Jun 30, 2025 | $13.40M | +343.8% |
| Q1 FY2025 | Mar 31, 2025 | $17.54M | +637.1% |
| Q4 FY2024 | Dec 31, 2024 | $14.85M | +347.6% |
| Q3 FY2024 | Sep 30, 2024 | $2.04M | -57.4% |
| Q2 FY2024 | Jun 30, 2024 | $3.02M | -34.2% |
| Q1 FY2024 | Mar 31, 2024 | $2.38M | -55.4% |
| Q4 FY2023 | Dec 31, 2023 | $3.32M | -52.8% |
| Q3 FY2023 | Sep 30, 2023 | $4.79M | -51.1% |
| Q2 FY2023 | Jun 30, 2023 | $4.59M | -40.3% |
| Q1 FY2023 | Mar 31, 2023 | $5.33M | -53.0% |
| Q4 FY2022 | Dec 31, 2022 | $7.03M | -49.8% |
| Q3 FY2022 | Sep 30, 2022 | $9.79M | -49.0% |
| Q2 FY2022 | Jun 30, 2022 | $7.70M | -64.8% |
| Q1 FY2022 | Mar 31, 2022 | $11.35M | -53.8% |
| Q4 FY2021 | Dec 31, 2021 | $14.01M | -53.0% |
| Q3 FY2021 | Sep 30, 2021 | $19.19M | +3744.3% |
| Q2 FY2021 | Jun 30, 2021 | $21.84M | +1982.5% |
| Q1 FY2021 | Mar 31, 2021 | $24.59M | +1958.2% |
| Q4 FY2020 | Dec 31, 2020 | $29.80M | +9530.5% |
| Q3 FY2020 | Sep 30, 2020 | $499.08K | – |
| Q2 FY2020 | Jun 30, 2020 | $1.05M | – |
| Q1 FY2020 | Mar 31, 2020 | $1.19M | – |
| Q4 FY2019 | Dec 31, 2019 | $309.38K | – |
See a number that looks wrong?